{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:12:33Z","timestamp":1772133153886,"version":"3.50.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Directorate General of Health Services"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Bangladesh became the first country globally to receive validation for the public health elimination of Visceral Leishmaniasis (VL). However, while VL cases have declined, sequels such as treatment failure and relapse are increasing. The current practice of assessing VL cure at six months post-treatment may delay the identification of sequelae. This study aims to determine the time required for VL patients to achieve complete clinical recovery and parasitological clearance, contributing to sustainable elimination efforts. We enrolled 50 confirmed VL patients from VL-endemic subdistricts of Mymensingh between June 2016 and March 2018. All the enrolled patients were treated with a single dose of Liposomal Amphotericin B (LAmB) (10 mg\/kg intravenous infusion). Blood samples were collected upon admission and monthly for six months post-treatment. Polymerase chain reaction (PCR) was performed on these samples. The Kaplan-Meier method was used to estimate the cumulative probability of cure time, with clinical and laboratory parameters measured monthly. The median cure time for the participants was one month. Within three months, 90% of the patients were cured, and all patients fully recovered by six months. A significant difference in cure time was noted between individuals with spleen sizes below and above 8 cm (p\u2009=\u20090.0002). Additionally, nutritional improvements were evident, with increased BMI and a decrease in underweight proportions. Hemoglobin levels showed significant improvement in the early months post-treatment, with complete resolution or significant reduction of splenomegaly observed in all patients by three months, prompting reconsideration of the final cure declaration to three months instead of six months after treatment. Adjusting this cure declaration (while retaining 6, 12, 24, 36, 48, and 60 months of follow-up) will facilitate early detection of non-responsive cases and optimize resource allocation crucial for sustaining VL elimination efforts.<\/jats:p>","DOI":"10.1371\/journal.pgph.0006002","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:33:56Z","timestamp":1772130836000},"page":"e0006002","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the optimum timeline for final cure assessment of treated Visceral Leishmaniasis patients in Bangladesh"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6784-7893","authenticated-orcid":true,"given":"Soumik Kha","family":"Sagar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-5326","authenticated-orcid":true,"given":"Shomik","family":"Maruf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajashree","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Masud Ur","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Aktaruzzaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Nazmul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheikh Daud","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Utba","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Rasel","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9274-432X","authenticated-orcid":true,"given":"Rupen","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faria","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-9414","authenticated-orcid":true,"given":"Debashis","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-8327","authenticated-orcid":true,"given":"Dinesh","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"pgph.0006002.ref001","author":"World Health Organization WHO","year":"2023"},{"issue":"5","key":"pgph.0006002.ref002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3201\/eid1105.040718","article-title":"Risk factors for kala-azar in Bangladesh","volume":"11","author":"C Bern","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"pgph.0006002.ref003","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"J Alvar","year":"2006","journal-title":"Trends Parasitol"},{"issue":"6","key":"pgph.0006002.ref004","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4269\/ajtmh.2003.69.624","article-title":"Visceral leishmaniasis: consequences of a neglected disease in a Bangladeshi community","volume":"69","author":"IB Ahluwalia","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"10151","key":"pgph.0006002.ref005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"S Burza","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"pgph.0006002.ref006","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"PJ Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"pgph.0006002.ref007","volume-title":"Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation","author":"World Health Organization","year":"2012"},{"key":"pgph.0006002.ref008","author":"World Health Organization WHO","year":"2021"},{"key":"pgph.0006002.ref009","author":"D Mondal","year":"2016"},{"key":"pgph.0006002.ref010","author":"World Health Organization WHO","year":"2023"},{"issue":"1","key":"pgph.0006002.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005190","article-title":"Investments in Research and Surveillance Are Needed to Go Beyond Elimination and Stop Transmission of Leishmania in the Indian Subcontinent","volume":"11","author":"PL Olliaro","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pgph.0006002.ref012","volume-title":"Regional technical advisory group on kala-azar elimination","author":"Delhi N","year":"2005"},{"issue":"3","key":"pgph.0006002.ref013","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40475-014-0027-6","article-title":"Kala-azar (Visceral Leishmaniasis) Elimination in Bangladesh: Successes and Challenges","volume":"1","author":"B-N Ahmed","year":"2014","journal-title":"Curr Trop Med Rep"},{"key":"pgph.0006002.ref014","author":"Ministry of Health and Family Welfare Bangladesh","year":"2013"},{"issue":"2","key":"pgph.0006002.ref015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"EE Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pgph.0006002.ref016","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftz057","article-title":"Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani","volume":"77","author":"MS Duthie","year":"2019","journal-title":"Pathog Dis"},{"issue":"8","key":"pgph.0006002.ref017","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.pt.2019.06.007","article-title":"Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission","volume":"35","author":"EA Le Rutte","year":"2019","journal-title":"Trends Parasitol"},{"key":"pgph.0006002.ref018","doi-asserted-by":"crossref","first-page":"670759","DOI":"10.3389\/fcimb.2021.670759","article-title":"Evaluation of Loopamp\u2122 Leishmania Detection Kit and Leishmania Antigen ELISA for Post-Elimination Detection and Management of Visceral Leishmaniasis in Bangladesh","volume":"11","author":"F Hossain","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"pgph.0006002.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185606","article-title":"Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment","volume":"12","author":"F Hossain","year":"2017","journal-title":"PLoS One"},{"key":"pgph.0006002.ref020","volume-title":"Stata Statistical Software: Release 17","author":"StataCorp","year":"2021"},{"key":"pgph.0006002.ref021","first-page":"676817","article-title":"Introducing single dose liposomal amphotericin B for the treatment of visceral leishmaniasis in rural bangladesh: feasibility and acceptance to patients and health staff","volume":"2014","author":"E-M Maintz","year":"2014","journal-title":"J Trop Med"},{"issue":"6","key":"pgph.0006002.ref022","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"S Sundar","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"pgph.0006002.ref023","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4269\/ajtmh.19-0179","article-title":"Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar","volume":"101","author":"S Sundar","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pgph.0006002.ref024","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(13)70118-9","article-title":"Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study","volume":"2","author":"D Mondal","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pgph.0006002.ref025","article-title":"Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial","volume":"8","author":"EAG Khalil","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pgph.0006002.ref026","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/377542","article-title":"Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study","volume":"37","author":"S Sundar","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pgph.0006002.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006527","article-title":"The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study","volume":"12","author":"C Abongomera","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pgph.0006002.ref028","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00436-022-07429-3","article-title":"Lethality among individuals infected with visceral leishmaniasis in Brazil: a retrospective study (2007-2018)","volume":"121","author":"LS Carvalho","year":"2022","journal-title":"Parasitol Res"},{"issue":"4","key":"pgph.0006002.ref029","doi-asserted-by":"crossref","first-page":"29","DOI":"10.20873\/uft.2446-6492.2020v7n4p29","article-title":"Perfil epidemiol\u00f3gico da leishmaniose visceral no brasil no per\u00edodo de 2007 a 2017; epidemiological profile of visceral leishmaniasis in brazil in the period from 2007 to 2017","volume":"7","author":"N De Carvalho Leite","year":"2021","journal-title":"Rev Pat Tocantins"},{"key":"pgph.0006002.ref030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1590\/S1415-790X2004000300011","article-title":"Leishmaniose visceral no Brasil: quadro atual, desafios e perspectivas","volume":"7","author":"CMF Gontijo","year":"2004","journal-title":"Rev Bras Epidemiol"},{"issue":"11","key":"pgph.0006002.ref031","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"F Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"pgph.0006002.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007726","article-title":"Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India","volume":"13","author":"V Goyal","year":"2019","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:34:02Z","timestamp":1772130842000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006002"}},"subtitle":[],"editor":[{"given":"Sakib","family":"Burza","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0006002","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}